Trial Details
RECRUITINGBasic Information
| Clinical ID | c1144 |
|---|---|
| Identifier | NCT05784246 |
| Trial Title | A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Mirikizumab IV|DRUG: Mirikizumab SC |
Participant Information
| Sponsor | Eli Lilly and Company |
|---|---|
| City | San Diego |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2023-11-22 |
|---|---|
| Primary Completion Date | 2025-07-26 |
| Completion Date | 2025-03-27 |